NAFLD: How to Diagnose and Prevent Non-Alcoholic Fatty Liver Disease: Non-Alcoholic Fatty Liver Disease is a disease that affects the liver cells and causes a build-up of fats that could potentially lead to liver failure. Alcoholic Fatty Liver Disease is a different liver condition from NAFLD and is caused by excessive drinking of alcohol. NAFLD […]
Read More… from How to diagnose and prevent Non-Alcoholic Fatty Liver Disease
New blood biomarker identified for status of fatty liver disease: A MedUni Vienna study team has identified the role of a specific subtype of macrophages (white blood cells) in progressive non-alcoholic fatty liver disease. As part of the immune system, these cells have a protective function against fibrosis and liver cirrhosis. At the same time, […]
A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of $1.3 million from IP Group, a UK-based intellectual property business. Jetra Therapeutics Pty Ltd is developing a treatment with the potential to reverse liver damage caused by Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic […]
Read More… from Start-up gets backing for liver disease treatment